(HealthDay)—The U.S. Food and Drug Administration approved the first drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA)-positive lesions in men with prostate cancer, the agency ...
8 hours ago
0
3
Following its approval in Scotland two weeks ago, a new treatment will now be available on the NHS in England for some people with prostate cancer.
Dec 01, 2020
0
4
For men with early-stage prostate cancer, choices about initial treatment carry varying risks of "financial toxicity," reports a study in The Journal of Urology, Official Journal of the American Urological Association (AUA). ...
Nov 30, 2020
0
3
Researchers at the Estonian Genome Center at the University of Tartu studied how people at high risk for breast, ovarian or prostate cancer responded to the feedback of genetic findings. Gene donors who chose to receive results ...
Nov 25, 2020
0
2
Medical mistrust is one reason why African American patients are more likely to have regrets about their choice of treatment for prostate cancer, suggests a study in The Journal of Urology, Official Journal of the American ...
Nov 24, 2020
0
2
Social needs—such as food and economic insecurity, poor housing and neighborhood conditions, and lack of access to transportation—were common in a group of African American cancer survivors in Detroit, and they were associated ...
Nov 23, 2020
0
1
Prostate cancer is the second-most diagnosed cancer in men after skin cancer. Approximately 1 of 9 men in the U.S. will get prostate cancer in his lifetime. Most men diagnosed with the disease won't die from it. More than ...
Nov 19, 2020
0
5
Prostate cancer is caused by elevated hormone levels, and tumors are generally treated using hormone therapy. However, after some time, tumor growth is no longer dependent on hormones, which results in resistance to treatment. ...
Nov 18, 2020
0
7
Can early-stage prostate cancer "vanish" during follow-up? More likely the cancer is just "hidden"—either way, negative biopsies during active surveillance for prostate cancer are associated with excellent long-term outcomes, ...
Nov 17, 2020
0
1
Prolonged androgen deprivation therapy (ADT) can impair cardiorespiratory fitness and increase risk of cardiovascular death in prostate cancer patients with high risk of cardiovascular disease, according to a study in JACC: ...
Nov 17, 2020
0
3
